Urgent.News

What's breaking now, across thousands of outlets.

Business

Gujarat Themis secures $58 million private credit for Japanese acquisition

Founded in 1981, Gujarat Themis is India's first company to start commercial production of the anti-tuberculosis drug Rifampicin, according to its website

Gujarat Themis secures $58 million private credit for Japanese acquisition

We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.

Read the original at business-standard.com →

More in Business

More from Tuesday 29 September →